Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value of its ecosystem of preclinical products to an entirely new level.

MILabs unique ecosystem of preclinical imaging products


Houten, The Netherlands, October 4, 2021 –  With its new series 7 integrated line of products, MILabs has focused on elevating the user experience by how well each modality works on its own and how much better when all of them work together. Molecular Image details that were previously obscured by blurring and noise can now be revealed in detail, and the enhanced integration of modalities in its ecosystem is pushing several applications to new levels. Preclinical imaging applications that were hereto out-of-reach are possible because of the interaction between modalities. These include one-on-one translation of SPECT to PET, fluorescence and bioluminescence tomography, nuclear microscopy, targeted radiotherapy with high-energy tracer capabilities. According to the company, any of its modalities can be added at any time to seamlessly complement its unique molecular imaging ecosystem.
Frederik Beekman, CEO/CSO clarifies the technology backbone: “MILabs has succeeded with its unique room-temperatures detection technologies to detect at high resolution a continuum of photons from 1eV to 1MeV. This encompasses popular PET, SPECT, Optical, and X-ray CT in vivo technologies for both diagnostic and therapeutic applications, as well as novel 3D ex vivo imaging techniques”.

About MILabs
MILabs B.V. (Houten, the Netherlands) is a global supplier of high-end molecular imaging solutions for biomedical and pharmaceutical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. The recent acquisition of MILabs by the Rigaku Group of Japan exemplifies further the value of the company’s products and technologies. For more information, visit www.milabs.com



Share on social media
Share on facebook
Share on twitter
Share on linkedin
Share on email

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. …

Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value …

Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs …

Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V …

Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” …

Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and …

Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of …

Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a …

Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress …

Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor …

Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting …

Read More →

The University of Southampton enters the field of Correlative In-Vivo Imaging by Acquiring MILabs 3D/4D Optical/CT

May 12, 2020, Southampton, UK – Utrecht, the Netherlands The Faculty of Medicine, University of …

Read More →
Scroll to Top